|
KIF4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01030295240889E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.17949999999201E-05 |
| Normal-vs-Stage2 |
9.395700E-02 |
| Normal-vs-Stage3 |
1.52235999999473E-05 |
| Normal-vs-Stage4 |
3.856000E-03 |
| Stage1-vs-Stage2 |
5.144400E-01 |
| Stage1-vs-Stage3 |
5.167600E-04 |
| Stage1-vs-Stage4 |
5.456000E-03 |
| Stage2-vs-Stage3 |
4.844200E-02 |
| Stage2-vs-Stage4 |
2.093200E-01 |
| Stage3-vs-Stage4 |
6.960000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.79319917090493E-11 |
| Normal-vs-AfricanAmerican |
7.377000E-04 |
| Normal-vs-Asian |
4.455500E-02 |
| Caucasian-vs-AfricanAmerican |
7.232600E-01 |
| Caucasian-vs-Asian |
1.760960E-01 |
| AfricanAmerican-vs-Asian |
1.355030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.93365373397137E-13 |
| Normal-vs-Female |
1.66729999999671E-05 |
| Male-vs-Female |
1.381700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.61670000000359E-05 |
| Normal-vs-Extreme_Weight |
5.14470000045897E-07 |
| Normal-vs-Obese |
1.54100000004931E-06 |
| Normal-vs-Extreme_Obese |
2.545500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.977700E-02 |
| Normal_Weight-vs-Obese |
9.846200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.424100E-04 |
| Extreme_Weight-vs-Obese |
2.142100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.778400E-03 |
| Obese-vs-Extreme_Obese |
6.341700000001E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.818500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.83659803715864E-11 |
| Normal-vs-Age(61-80Yrs) |
2.05299999999076E-05 |
| Normal-vs-Age(81-100Yrs) |
3.415500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.567700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.432400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.934420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.356600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.274400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.704400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.53120000012663E-08 |
| Normal-VS-Type2 PRCC |
9.91810000017246E-07 |
| Normal-VS-KIRP CIMP |
8.810000E-04 |
| Normal-VS-Unclassified PRCC |
2.170500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.937800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.782930E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.813900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.304200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.489000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.424300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.425900E-04 |
| Normal-vs-N1 |
1.68929999999623E-06 |
| Normal-vs-N2 |
9.638000E-02 |
| N0-vs-N1 |
5.037400E-04 |
| N0-vs-N2 |
6.843700E-02 |
| N1-vs-N2 |
7.284600E-01 |
|
|
